{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:46:04Z","timestamp":1790318764705,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACTS<\/jats:title>\n                  <jats:p>The technological developments associated with the branch of Radiation Oncology have been directed towards precise delivery of the dose, leading to improved survival in various solid malignancies. Radiation therapy as a treatment modality, is an integral component of more than half of the diagnosed malignancies. In spite of the role of adaptive radiation therapy evolving over the last decade, the fundamental question remains as to the difference in radiation response between individuals. Recently, the role of the radiosensitivity index has emerged, which has shown immense potential in the development of biologically driven tumor radiation therapy. The role of these novel methods of genome-based molecular assays needs to be explored to help in decision-making between radical treatment options for various malignancies and reduce the associated toxicity burden. In this article, we explore the current evidence available for various malignancy sites and provide a comprehensive review of the predictive values of various molecular markers available and their impact on the radiosensitivity index.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_508_23","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T03:01:21Z","timestamp":1708484481000},"page":"S508-S512","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Personalized medicine in radiation oncology and radiation sensitivity index: Pathbreaking genomic way to define the role of radiation in cancer management"],"prefix":"10.4103","volume":"19","author":[{"given":"Dodul","family":"Mondal","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Max Super Speciality Hospitals, Saket, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhay","family":"Pareek","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Care, Manitoba, Winnipeg, MB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Barthwal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Care, Manitoba, Winnipeg, MB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype","volume":"9","author":"Barnett","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-8140(90)90202-8","article-title":"The ESTRO Regaud lecture. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response","volume":"17","author":"Peters","year":"1990","journal-title":"Radiother Oncol"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000421-198806000-00005","article-title":"Predictive assays of tumor radiocurability","volume":"11","author":"Peters","year":"1988","journal-title":"Am J Clin Oncol"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.1125948","article-title":"Cancer biomarkers--An invitation to the table","volume":"312","author":"Dalton","year":"2006","journal-title":"Science"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nbt1004-1215","article-title":"The impact of systems approaches on biological problems in drug discovery","volume":"22","author":"Hood","year":"2004","journal-title":"Nat Biotechnol"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1069492","article-title":"Systems biology: A brief overview","volume":"295","author":"Kitano","year":"2002","journal-title":"Science"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1104635","article-title":"Systems biology and new technologies enable predictive and preventative medicine","volume":"306","author":"Hood","year":"2004","journal-title":"Science"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/107327480801500207","article-title":"Predicting response to clinical radiotherapy: Past, present, and future directions","volume":"15","author":"Torres-Roca","year":"2008","journal-title":"Cancer Control"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-20241021","first-page":"PO.18.00034","article-title":"Applying precision oncology principles in radiation oncology","volume":"2","author":"Kamran","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijrobp.2017.05.044","article-title":"Precision oncology and genomically guided radiation therapy: A report from the American Society for Radiation Oncology\/American Association of Physicists in Medicine\/National Cancer Institute Precision Medicine Conference","volume":"101","author":"Hall","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijrobp.2009.06.014","article-title":"A gene expression model of intrinsic tumor radiosensitivity: Prediction of response and prognosis after chemoradiation","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ijrobp.2009.05.056","article-title":"Systems biology modeling of the radiation sensitivity network: A biomarker discovery platform","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"34414","DOI":"10.18632\/oncotarget.5437","article-title":"The radiosensitivity index predicts for overall survival in glioblastoma","volume":"6","author":"Ahmed","year":"2015","journal-title":"Oncotarget"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): A retrospective, cohort-based study [published correction appears in Lancet Oncol 2017 Feb; 18(2):e65]","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/neuonc\/nox043","article-title":"The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity","volume":"19","author":"Ahmed","year":"2017","journal-title":"Neuro Oncol"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1158\/1078-0432.CCR-12-0891","article-title":"Validation of a radiosensitivity molecular signature in breast cancer","volume":"18","author":"Eschrich","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijrobp.2015.06.021","article-title":"Integration of a radiosensitivity molecular signature into the assessment of local recurrence risk in breast cancer","volume":"93","author":"Torres-Roca","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ebiom.2019.08.019","article-title":"Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management","volume":"47","author":"Ahmed","year":"2019","journal-title":"EBioMedicine"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"849","DOI":"10.21037\/jtd.2017.03.23","article-title":"The mechanisms of radioresistance in esophageal squamous cell carcinoma and current strategies in radiosensitivity","volume":"9","author":"Chen","year":"2017","journal-title":"J Thorac Dis"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1471-2164-13-348","article-title":"Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells","volume":"13","author":"Kim","year":"2012","journal-title":"BMC Genomics"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ijrobp.2015.01.036","article-title":"Differences between colon cancer primaries and metastases using a molecular assay for tumor radiation sensitivity suggest implications for potential oligometastatic SBRT patient selection","volume":"92","author":"Ahmed","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2016.03.050","article-title":"Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy","volume":"95","author":"Ahmed","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jtho.2018.04.027","article-title":"Radiosensitivity of lung metastases by primary histology and implications for stereotactic body radiation therapy using the genomically adjusted radiation dose","volume":"13","author":"Ahmed","year":"2018","journal-title":"J Thorac Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_508_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:30Z","timestamp":1787067510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_508_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":25,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_508_23","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2023-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}